Carbohydrate-deficient transferrin in the assessment of harmful alcohol consumption: Diagnostic performance and clinical significance

Addiction Biology

Volumn 4, Issue 2, 1999, Pages 151-161

  Bean, Pamela ^a,b  

^a Specialty Laboratories   (United States)

^b Millennium Strategies   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MARKER; OLIGOSACCHARIDE; TRANSFERRIN;

ALCOHOL ABUSE; ALCOHOL CONSUMPTION; ALCOHOL METABOLISM; ALCOHOLISM; AUTOMATION; BEER; ENZYME IMMUNOASSAY; GLYCOSYLATION; HUMAN; IMMUNOBLOTTING; ION EXCHANGE CHROMATOGRAPHY; ISOELECTRIC FOCUSING; LIVER CELL; NEPHELOMETRY; PREVALENCE; PRIORITY JOURNAL; RADIOIMMUNOASSAY; REVIEW; SCREENING TEST; TRANSFERRIN BLOOD LEVEL; WINE;

EID: 0032930014     PISSN: 13556215     EISSN: None     Source Type: Journal    
DOI: 10.1080/13556219971650     Document Type: Review

References (59)

1. Stibler H. Carbohydrate-deficient transferrin in serum: a new marker of potentially harmful alcohol consumption reviewed. Clin Chem 1991;37: 2029-37.
2. Godsell PA, Whitfield JB, Conigrave KM, et al. Carbohydrate deficient transferrin levels in hazardous alcohol consumption. Alcohol Alcohol 1995; 30:61-6.
3. Rosman AS, Lieber CS. An overview of current and emerging markers of alcoholism. In: Litten RZ, Allen JP, editors. Measuring alcohol consumption. Totowa, New Jersey: Humana Press; 1992, pp. 99-134.
4. Allen JP, Litten RZ, Anton RF, et al. Carbohydrate-deficient transferrin as a measure of immoderate drinking: remaining issues. Alcohol Clin Exp Res 1994;18:799-812.
5. Stibler H, Kjellin KG. Isoelectric focusing and electrophoresis of the CSF proteins in tremors of different origins. J Neurol Sci 1976;30: 269-85.
6. Stibler H, Allgulander C, Borg S, et al. Abnormal microheterogeneity of transferrin in serum and cerebrospinal fluid in alcoholism. Acta Med Scand 1978;204:49-56.
7. Secretary of Health and Human Services. Ninth special report to the U.S. Congress on alcohol and health, Washington DC: Government Printing Office; NIH publication no. 97-4017. 1997.
8. Xin Y, Lasker JM, Lieber CS. Serum carbohydrate-deficient transferrin: mechanism of increase after chronic alcohol transferrin: mechanism of increase after chronic alcohol intake. Hepatoloty 1995;22: 1462-8.
9. Guash R, Renau-Piqueras J, Guerri C. Chronic ethanol consumption induces accumulation of proteins in the liver Golgi apparatus and decreases galactosyltransferase activity. Alcohol Clin Exp Res 1992;16:942-8.
10. Putnam FW. Transferrin. In: Putnam FW, editor. The plasma proteins. New York, NY: Academic Press, 1975;266-316.
11. Jong G, van Dijk JB, Eijk HG. The biology of transferrin. Clin Chem Acta 1990;190:1-46.
12. Bean P, Liegmann K, Lovli T, et al. Semiautomated procedures for evaluation of CDT in the diagnosis of alcohol abuse. Clin Chem 1997; 43:983-9.
13. Martensson O, Harlin A, Brandt R, et al. Transferrin isoform distribution: gender and alcohol consumption. Alcohol Clin Exp Res 1997;21: 1710-15.
14. Stibler H, Borg S, Joustra M. Micro anion exchange chromatography of carbohydrate-deficient transferrin in serum in relation to alcohol consumption (Swedish Patent 8400587-5). Alcohol Clin Exp Res 1986;10:535-44.
15. Bean P, Peter JB. A new approach to quantitate carbohydrate deficient transferrin isoforms in alcohol abusers: Partial iron saturation in isoelectric focusing/immunoblotting and laser densitometry. Alcohol Clin Exp Res 1993;17:1163-70.
16. Jeppsson JO, Kristensson H, Fimiani C. Carbohydrate-deficient transferrin quantified by HPLC to determine heavy consumption of alcohol. Clin Chem 1993;39:2115-20.
17. Werle E, Seitz GE, Kohl B: et al. High-performance liquid chromatography improves diagnostic efficiency of carbohydrate-deficient transferrin. Alcohol Alcohol 1997;32:71-7.
18. Anton R, Bean P. Two methods for measuring carbohydrate-deficient transferrin in inpatient alcoholics and healthy controls compared. Clin Chem 1994;40:364-8.
19. Stibler H, Borg S, Joustra M. A modified method for the assay of carbohydrate deficient transferrin in serum. Alcohol Alcohol 1991; Suppl. 1:451-4.
20. Sorvajarvi K, Blake JE, Israel Y, et al. Sensitivity and specificity of carbohydrate-deficient transferrin as a marker of alcohol abuse are significantly influenced by alterations in serum transferrin: comparison to two methods. Alcohol Clin Exp Res 1996;20:449-54.
21. Bean P. Evaluation of carbohydrate deficient transferrin - letter reply to the Editor. Clin Chem; 1998, in press.
22. Zweig MH, Campbell G. Receiver-operating characteristic (ROC) plots: a fundamental evaluation of clinical medicine [review]. Clin Chem 1993;39: 561-77.
23. Lesch OM, Walter H, Antal J, et al. Carbohydrate-deficient transferrin as a marker of alcohol intake: A study with healthy subjects. Alcohol Alcohol 1996;31:265-71.
24. Bean P, Peter JB. Allelic D variants of transferrin in evaluation of alcohol abuse: differential diagnosis by isoelectric focusing-immunoblotting-laser densitometry. Clin Chem 1994;40:2078-83.
25. Stibler H, Jaeken J. Carbohydrate deficient serum transferrin in a new systemic hereditary syndrome. Arch Dis Child 1990;65:107-11.
26. Arndt T, Hackler R, Muller T, et al. Increased serum concentration of carbohydrate-deficient transferrin in patients with combined pancreas and kidney transplantation. Clin Chem 1997;43: 344-51.
27. Bean P, Sutphin MS, Liu YS, et al. Carbohydrate-deficient transferrin and false-positive results for alcohol abuse in primary biliary cirrhosis: differential diagnosis by detection of mitochondrial autoantibodies. Clin Chem 1995;41:858-61.
28. Perret R, Froehlich F, Lavanchy D, et al. Is carbohydrate-deficient transferrin a specific marker for alcohol abuse? A study in patients with chronic viral hepatitis. Alcohol Clin Exp Res 1997;21: 1337-42.
29. Murawaki Y, Sugisaki H, Yuasa I, et al. Serum carbohydrate-deficient transferrin in patients with nonalcoholic liver disease and with hepatocellular carcinoma. Clin Chim Acta 1997; 259:97-108.
30. Vermes I, van den Bergh F. Clinical utility of carbohydrate-deficient transferrin to detect alcohol abuse in a general population [letter]. Clin Chem 1996;12:1-2.
31. Nilssen O, Huseby NE, Hoyer G, et al. New alcohol markers-how useful are they in population studies: the Svalbard Study 1988-89. Alcohol Clin Exp Res 1997;16:82-6.
32. Bell H, Tallaksen CME, Try K, et al. Carbohydrate-deficient transferrin and other markers of high alcohol consumption: a study of 502 patients admitted consecutively to a medical department. Alcohol Alcohol 1994;18:1103-8.
33. Gronbaek M, Henriksen JH, Becker U. Carbohydrate-deficient transferrin - a valid number of alcoholism in population studies? Results from the Copenhagen City Heart Study. Alcohol Clin Exp Res 1995:19:457-61.
34. Lesch O, Walter H, Freitag H, et al. Carbohydrate-deficient transferrin as a screening marker for drinking in a general hospital population. Alcohol Alcohol 1996:31:249-56.
35. Yersin B, Nicolet JF, Decrey H, et al. Screening for excessive alcohol drinking. Comparative value of carbohydrate-deficient transferrin, γ-glutamyl-transferase, and mean corpuscular volume. Arch Intern Med 1995;155:1907-11.
36. Anton RF, Moak DH. Carbohydrate-deficient transferrin and γ-glutamyltransferase as markers of heavy alcohol consumption: gender differences. Alcohol Clin Exp Res 1994;18:747-54.
37. La Grange L, Anton RF, Crow H, et al. A correlational study of carbohydrate-deficient transferrin (CDT values and alcohol consumption among Hispanic college students). Alcohol Clin Exp Res 1995;19:100-3.
38. Stauber RE, Vollmann H, Pesserl I, et al. Carbohydrate-deficient transferrin in healthy women: relation to estrogens and iron status. Alcohol Clin Exp Res 1996;20:1114-7.
39. Jensen PD, Peterslund NA, Poulsen JH, et al. The effect of iron overload and iron reductive treatment on the serum concentration of carbohydrate-deficient transferrin. Br J Haematol 1994;88:56-63.
40. Stauber RE, Jauk B, Fickert P, et al. Increased carbohydrate-deficient transferrin during preganancy: relation to sex hormones. Alcohol Alcohol 1996;31:389-392.
41. Hagen M. Test characteristics. How good is that test? Med Dec Making 1995;22:213-33.
42. Rowe PM. Alcoholism in USA [letter]. Lancet 1996;347:850.
43. Sillanaukee P. Laboratory markers of alcohol abuse. Alcohol Alcohol 1996;31:613-16.
44. Salmela KS, Laitinen K, Mystrom M, et al. Carbohydrate-deficient transferrin during 3 weeks' heavy alcohol consumption. Alcohol Clin Exp Res 1994;18:228-30.
45. Bell H, Tallaksen C, Sjaheim T, et al. Serum carbohydrate-deficient transferrin as a marker of alcohol consumption in patients with chronic liver diseases. Alcohol Clin Exp Res 1993;17:246-52.
46. Niemel O, Sorvajarvi K, Blake JE, et al. Carbohydrate-deficient transferrin as a marker of alcohol abuse: relationship to alcohol consumption, severity of liver disease, and fibrogenesis. Alcohol Clin Exp Res 1995;19:1203-8.
47. Meregalli M, Giacomini V, Silvana L, et al. Carbohydrate-deficient transferrin in alcohol and non-alcohol abusers with liver disease. Alcohol Clin Exp Res 1995;19:1525-7.
48. Stauber RE, Stepan V, Trauner M, et al. Evaluation of carbohydrate-deficient transferrin for detection of alcohol abuse in patients with liver dysfunction. Alcohol Alcohol 1995;30:171-6.
49. Radosavljevic M, Temsch E, Hammer J, et al. Elevated levels of carbohydrate-deficient transferrin are not specific for alcohol abuse in patients with liver disease. J Hepatol 1995;23:706-11.
50. Stibler H. Diagnosis of alcohol-related neurological diseases by analysis of carbohydrate-deficient transferrin in serum. Acta Neurol Scand 1993;88: 279-83.
51. Bean P, Daniel P. Carbohydrate-deficient transferrin: current facts and future projections for the insurance industry. On The Risk 1996;12:43-8.
52. Behrens UJ, Worner TM, Lieber CS. Changes in carbohydrate-deficient transferrin levels after alcohol withdrawal. Alcohol Clin Exp Res 1988;12: 539-44.
53. Helander A, Carlsson AV, Borg S. Longitudinal comparison of carbohydrate-deficient transferrin and gamma-glutamyl transferase: complementary markers of excessive alcohol consumption. Alcohol Alcohol 1996;31:101-7.
54. Lesch OM, Walter H, Antal J, et al. Alcohol dependence: is carbohydrate-deficient transferrin a marker for alcohol intake? Alcohol Alcohol 1996; 31:257-64.
55. Anton RF, Moak DH, Latham P. Carbohydrate-deficient transferrin as an indicator of drinking status during a treatment outcome study. Alcohol Clin Exp Res 1996;20:841-6.
56. Anton RF. New methodologies for pharmacological treatment trials for alcohol dependence. Alcohol Clin Exp Res 1996;20:3A-9A.
57. Borg S, Helander A, Voltaire CA, et al. Detection of relapses in alcohol-dependent patients using carbohydrate-deficient transferrin: improvement with individualized reference levels during long-term monitoring. Alcohol Clin Exp Res 1995;19: 961-73.
58. Rosman AS, Basu P, Galvin K, et al. Utility of carbohydrate-deficient transferrin as a marker of relapse in alcoholic patients. Alcohol Clin Exp Res 1995;19:611-16.
59. Linnoila M, Fawcett J, Fuller RK, et al. Evaluation of pharmacologic treatments for alcohol abuse, dependence, and their complications. In: Prien RF, Robinson DS, editors. Clinical evaluation of psychotropic drugs: principles and guidelines. New York: Raven Press; 1994, pp. 625-649.